9696 Results
1

COVID-19 may attack patients’ central nervous system

July 14, 2020

Ahmad Sedaghat, MD, PhD, conducted a prospective, cross-sectional telephone questionnaire study which examined characteristics and symptoms of 114 patients who were diagnosed with COVID-19 over a six-week period at Kantonsspital Aarau in Aarau, Switzerland. Depressed mood or anxiety exhibited in COVID-19 patients may possibly be a sign the virus affects the central nervous system, according to Sedaghat, a University of Cincinnati College of Medicine researcher.

2

Bad E. coli we know, but good E. coli?

July 7, 2020

Researchers at the University of Cincinnati College of Medicine say E. coli Nissle may protect human cells against other more pathogenic strains of E. coli such as E. coli 0157:H7, which is commonly associated with contaminated hamburger meat.

3

Autoclaving, alcohol not the best options for disinfecting, reusing face masks

July 12, 2020

A University of Cincinnati researcher is advising against using a widely available sterilization method to clean disposable surgical masks and N95 respirators for reuse in the midst of the coronavirus pandemic. Scarcity of personal protection equipment in medical settings has led many health systems to consider sterilizing and reusing masks developed initially as disposable items, says Sergey Grinshpun, PhD, director of the University of Cincinnati Center for Health-Related Aerosol Studies and professor in the UC Department of Environmental and Public Health Sciences.

4

UC scientist battles disease up close and in the laboratory

September 24, 2020

Dr. Katherine Burns' experience with endometriosis fuels her research to find a cure for a disease that affects one in 10 women. The University of Cincinnati researcher was recently awarded a five-year $2.1 million grant from the National Institutes of Health to look more closely at how the immune system may play a role in the development of endometriosis.

5

UC research produces different results from key China COVID-19 investigation

September 17, 2020

Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger patient population and reached completely different findings. The study was published in the journal Progress in Cardiovascular Diseases in mid-July.

6

UC students create UV box to aid Crossroad Health Center in midst of COVID-19

April 30, 2020

Dis-Box is an ultraviolet box designed by a group of University of Cincinnati engineering students that may help extend use of personal protective equipment (PPE) for healthcare workers at Cincinnati’s Crossroad Health Center. UC family medicine professor Christine O'dea put a call for help when faced with a shortage of PPE and the engineering students and their professor Mary Beth Privitera answered the call.

7

UC medical students hone first response skills

August 24, 2020

As part of first-responder training, all first-year medical students at the University of Cincinnati College of Medicine are required to master a set of skills they can use to assess and stabilize a person in distress until emergency medical services arrive. The medical students become CPR-certified but they also know how to stop life-threatening bleeding with a tourniquet or wound packing and how to stabilize a cervical spine or apply a cervical collar. They can assist with supplemental oxygen or positive pressure ventilation. The training program has been in place at the college for a decade.

8

UC invests in a commitment to cutting edge technology

June 30, 2022

The University of Cincinnati is making a significant commitment of funds and resources to establish single particle cryo-electron microscopy as the focal point of the Center for Advanced Structural Biology in the College of Medicine. The project will be built out in three phases over the next five years.

9

Using bacteria to target cancer treatment

March 28, 2023

Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.